InhaleRx (ASX:IRX) Accounts Payable : A$0.37 Mil (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Accounts Payable?

InhaleRx's Accounts Payable for the quarter that ended in Jun. 2023 was A$0.37 Mil.

InhaleRx's quarterly Accounts Payable declined from Jun. 2022 (A$0.31 Mil) to Dec. 2022 (A$0.12 Mil) but then increased from Dec. 2022 (A$0.12 Mil) to Jun. 2023 (A$0.37 Mil).

InhaleRx's annual Accounts Payable increased from Dec. 2021 (A$0.07 Mil) to Dec. 2022 (A$0.12 Mil) and increased from Dec. 2022 (A$0.12 Mil) to Dec. 2023 (A$0.18 Mil).

InhaleRx Accounts Payable Historical Data

The historical data trend for InhaleRx's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Accounts Payable Chart

InhaleRx Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.05

0.13

0.07

0.12

0.18

InhaleRx Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial									0.07	0.31	0.12	0.37	0.18

InhaleRx Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

InhaleRx Accounts Payable Related Terms

Thank you for viewing the detailed overview of InhaleRx's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

InhaleRx (ASX:IRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.inhalerx.com.au

InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx (ASX:IRX) Headlines

No Headlines